Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 06, 2019
Novasep announced Enzene Biosciences has chosen BioSC Pilot for purification of biopharmaceuticals to operate in its Pune plant.
read more
Tuesday, September 23, 2025
Enzene announced the initiation of commercial supply of pertuzumab, a monoclonal antibody (mAb) therapy indicated for the treatment of HER2-positive (HER2+) breast cancer. The product will be marketed in India by multiple leading pharmaceutical ...
read more
Enzo Biochem announced the official launch of the Company’s new 100,000 square foot state-of-the-art laboratory and research facilities in Farmingdale, New York.
read more
Thursday, October 07, 2021
Samsung Biologics and Enzolytics (ENZC) announced the signing of a strategic CDMO partnership agreement. Under the terms of the agreement, Samsung Biologics will provide end-to-end CDMO services from cell line development, clinical drug substance, ...
read more
Wednesday, April 19, 2017
ePatientFinder®, a provider of EHR-driven clinical trial site optimization and patient identification, and Rep Network, an independent sales and knowledge source for the healthcare industry, have announced an alliance that will expand clinical trial ...
read more
Epic Sciences has named Chockalingam "Palani" Palaniappan as its new CTO to help the company advance its Functional Cell Profiling technology to drive global expansion.
read more
Epic Sciences announced today an agreement with Laboratory Corporation of America® Holdings to provide circulating tumor cell (CTC) technology and support oncology clinical trials in Asia through Covance Drug Development
read more
Wednesday, April 24, 2019
EpimAb Biotherapeutics announced the USPTO has granted the U.S. Patent No. 10,266,608 entitled “Fabs-In-Tandem Immunoglobulin and Uses Thereof.”
read more
Tuesday, October 09, 2018
Supply Chain Wizard and Epista Life Science ApS have partnered to support their clients beyond serialization compliance deadlines.
read more
Epistem announces that following investment by Foresight Group it has completed a management buy-out (MBO) from genedrive plc.
read more
EpiVax, Inc. announces participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic Preparedness Innovations), to develop universal vaccines for betacoronaviruses, including SARS-CoV-2. EpiVax will be carrying out the vaccine...
read more
Epizyme, Inc. has entered into two Cooperative Research and Development Agreements (CRADAs) with the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). The CRADAs will evaluate tazemetostat, Epizyme’s first-in-class EZH2...
read more
Eppendorf expands its portfolio of rigid-wall single-use vessels for fermentation. The newly launched Eppendorf BioBLU® 3f was developed specifically for microbial bioprocessing in working volumes of 1.25 to 3.75 L, extending the full range of ...
read more
Monday, September 22, 2014
The rise of high value specialty pharmaceuticals, growth of the generics market, smaller order sizes and increasing label complexity are driving demand for shorter batch color labels. With the Drug Quality and Security Act’s (DQSA) impending ...
read more
Thursday, November 18, 2021
EQRx, and Evotec SE announced a collaboration to design, discover and develop new therapeutic options for patients. The collaboration will help accelerate EQRx’s pipeline expansion efforts by leveraging Evotec’s unique data-driven, fully integrated R...
read more